Alpha 0.1.0

Biotech411

Biotechnology. Right now.

All programs

Oncology

Jemperli · rectal cancer

Accelerated approval · As of

AZUR-1 enrolled patients with previously untreated stage II or III locally advanced rectal cancer with MSI-high or mismatch-repair-deficient tumors.

Milestone history

  1. ClinicalTrials.gov first posted the AZUR-1 study record (NCT05723562).

    ClinicalTrials.gov
  2. AZUR-1 began enrolling patients, according to the study record.

    ClinicalTrials.gov
  3. FDA granted accelerated approval for the biomarker-defined rectal cancer indication.

    FDA